Expression des Natriumiodid- Symporters bei differenzierten Schilddrüsenkarzinomen: klinischer Stellenwert*
暂无分享,去创建一个
G. Schmitz | Johannes Meller | M. Hüfner | C. Sahlmann | L. Füzesi | J. Struck | U. Siefker | A. Hamann
[1] O. Schober,et al. Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 2) , 2004, Nuklearmedizin.
[2] J. Bidart,et al. Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Shu-mei Lai,et al. Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells. , 2003, The Journal of clinical endocrinology and metabolism.
[4] O. Schober,et al. Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2) , 2003, Nuklearmedizin.
[5] C. Reiners,et al. Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 2) , 2003, Nuklearmedizin.
[6] K. Hahn,et al. Stunning effects in radioiodine therapy of thyroid carcinoma , 2003, Nuklearmedizin.
[7] T. Petrich,et al. Functional activity of human sodium/iodide symporter in tumor cell lines , 2003, Nuklearmedizin.
[8] I. Hay,et al. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. , 2001, The Journal of clinical endocrinology and metabolism.
[9] Z. Baloch,et al. Rapid communication: predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases. , 2001, The Journal of clinical endocrinology and metabolism.
[10] C. Shriver,et al. Expression of the Sodium Iodide Symporter and Thyroglobulin Genes Are Reduced in Papillary Thyroid Cancer , 2001, Modern Pathology.
[11] D. Lee,et al. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma , 2001, European Journal of Nuclear Medicine.
[12] S. Filetti,et al. Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas. , 2000, European journal of endocrinology.
[13] J. D. Lin,et al. Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] G. Gong,et al. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. , 2000, Thyroid : official journal of the American Thyroid Association.
[15] P. Roche,et al. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. , 1999, The Journal of endocrinology.
[16] V. Lazar,et al. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. , 1999, The Journal of clinical endocrinology and metabolism.
[17] J. Goellner,et al. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. , 1999, The Journal of clinical endocrinology and metabolism.
[18] E. Baudin,et al. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study. , 1998, The Journal of clinical endocrinology and metabolism.
[19] S. Filetti,et al. Iodide symporter gene expression in human thyroid tumors. , 1998, The Journal of clinical endocrinology and metabolism.
[20] Qing-Rong Liu,et al. Cloning of the human sodium lodide symporter. , 1996, Biochemical and biophysical research communications.
[21] M. Schlumberger,et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] N. Carrasco,et al. Cloning and characterization of the thyroid iodide transporter , 1996, Nature.
[23] C. Fisher,et al. TNM Atlas. Illustrated Guide to the TNM/pTNM-Classification of Malignant Tumours , 1990 .
[24] L. Sobin,et al. The WHO histological classification of thyroid tumors: A commentary on the second edition , 1989, Cancer.
[25] D. Berman,et al. The significance of 1-131 scan dose in patients with thyroid cancer: determination of ablation: concise communication. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] T. Leitha,et al. Frequency of diagnostic dilemmas in 131I whole body scanning , 2003, Nuklearmedizin.